A Study to Evaluate the Efficacy and Safety of Hetrombopag Olamine Tablets Vs Placebo in Patients With Chemotherapy-Induced Thrombocytopenia
Public ClinicalTrials.gov record NCT07286032. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Randomized, Multi-Center, Double-Blind, Phase III Study Evaluating the Efficacy and Safety of Hetrombopag Olamine Tablets Vs Placebo in Patients With Chemotherapy-Induced Thrombocytopenia
Study identification
- NCT ID
- NCT07286032
- Recruitment status
- Recruiting
- Study type
- Interventional
- Phase
- Phase 3
- Lead sponsor
- Jiangsu HengRui Medicine Co., Ltd.
- Industry
- Enrollment
- 150 participants
Conditions and interventions
Interventions
- Hetrombopag Olamine Drug
- Hetrombopag Olamine ；Hetrombopag Olamine Placebo Drug
Drug
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Apr 15, 2026
- Primary completion
- Nov 30, 2028
- Completion
- May 31, 2029
- Last update posted
- Jul 13, 2026
2026 – 2029
United States locations
- U.S. sites
- 7
- U.S. states
- 6
- U.S. cities
- 7
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Cancer and Blood Specialty Clinic | Los Alamitos | California | 90254 | Not yet recruiting |
| AdventHealth Hematology and Oncology Denver Cypress Hematology and Oncology | Denver | Colorado | 80210 | Not yet recruiting |
| Oncology & Hematology Associates of West Broward | Coral Springs | Florida | 33065 | Not yet recruiting |
| Mid-Florida Hematology & Oncology Centers, P.A. | Orange City | Florida | 32763 | Recruiting |
| Springfield Clinic | Springfield | Illinois | 62702 | Not yet recruiting |
| Morristown Medical Center | Morristown | New Jersey | 07039 | Not yet recruiting |
| New York Cancer and Blood Specialists One Oncology | Shirley | New York | 11967 | Not yet recruiting |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT07286032, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Jul 13, 2026 · Synced Jul 23, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT07286032 live on ClinicalTrials.gov.